GnRHagonistのゴナドトロピン放出刺激作用を用いた無排卵治療と負荷試験としての有用性について

書誌事項

タイトル別名
  • Gonadotrophin-Releasing Hormone Agonist in the Treatment of Hypogonadotrophic Secondary Amenorrhoea

この論文をさがす

抄録

In an attempt to induce ovulation in Clomiphene resistant secondary amenorrhoea patients, the gonadotrophin-releasing hormone agonist (Buserelin)(600-900μg/day) was administered in 13 cases aged 18 to 24 years for one week from day 5 of the menstrual cycle. Serum levels of luteinizing hormone increased in all patients, and estradiol levels increased in 10 of 13 patients in response to Buserelin. However, ovulation was observed in 6 cases, and the response to Clomiphene was recovered in all of these 6 cases in their subsequent menstrual cycles. These results imply the existence of a subgroup who respond to Buserelin in Clomiphene resistant secondary amenorrhoea patients and a possible new approach for the treatment of secondary amenorrhoea.

収録刊行物

詳細情報 詳細情報について

問題の指摘

ページトップへ